       Document 0400
 DOCN  M9440400
 TI    [Is resistance of human immunodeficiency viruses (HIV) to nucleoside
       analogs an indication for their combined use?]
 DT    9404
 AU    Pepin JM; Simon F; Brun-Vezinet F; Laboratoire de Virologie, Hopital
       Bichat-Claude Bernard, Paris,; France.
 SO    Pathol Biol (Paris). 1993 Oct;41(8 Pt 2):788-93. Unique Identifier :
       AIDSLINE MED/94143074
 AB    HIV resistance to nucleoside analogues such as zidovudine (AZT) is to
       date a source of concern, even if its clinical significance is yet to be
       determined. Phenotypic and genotypic data concerning HIV resistance will
       be presented, then the potential benefits of nucleoside combinations
       will be discussed.
 DE    Acyclovir/PHARMACOLOGY  Didanosine/*PHARMACOLOGY  Drug Synergism  Drug
       Therapy, Combination  English Abstract  Female  Foscarnet/PHARMACOLOGY
       Human  HIV-1/*DRUG EFFECTS  In Vitro  Male  Ribavirin/*PHARMACOLOGY
       Zalcitabine/*PHARMACOLOGY  Zidovudine/*PHARMACOLOGY  JOURNAL ARTICLE
       REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

